These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26745211)

  • 1. Prevalence and Treatment Outcomes of Persistent Negative Mood Among Children with Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior.
    Blader JC; Pliszka SR; Kafantaris V; Sauder C; Posner J; Foley CA; Carlson GA; Crowell JA; Margulies DM
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):164-73. PubMed ID: 26745211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
    Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
    J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
    Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.
    Mayes SD; Waxmonsky JD; Calhoun SL; Bixler EO
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):101-6. PubMed ID: 26745442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).
    Fernández de la Cruz L; Simonoff E; McGough JJ; Halperin JM; Arnold LE; Stringaris A
    J Am Acad Child Adolesc Psychiatry; 2015 Jan; 54(1):62-70.e3. PubMed ID: 25524791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
    Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.
    Blader JC; Pliszka SR; Kafantaris V; Foley CA; Carlson GA; Crowell JA; Bailey BY; Sauder C; Daviss WB; Sinha C; Matthews TL; Margulies DM
    J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):236-251. PubMed ID: 32007604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates.
    Freeman AJ; Youngstrom EA; Youngstrom JK; Findling RL
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):123-30. PubMed ID: 26745325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Clinical Trial of Dialectical Behavior Therapy for Preadolescent Children With Disruptive Mood Dysregulation Disorder: Feasibility and Outcomes.
    Perepletchikova F; Nathanson D; Axelrod SR; Merrill C; Walker A; Grossman M; Rebeta J; Scahill L; Kaufman J; Flye B; Mauer E; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2017 Oct; 56(10):832-840. PubMed ID: 28942805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation.
    Waxmonsky JG; Waschbusch DA; Belin P; Li T; Babocsai L; Humphery H; Pariseau ME; Babinski DE; Hoffman MT; Haak JL; Mazzant JR; Fabiano GA; Pettit JW; Fallahazad N; Pelham WE
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):196-207. PubMed ID: 26903253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
    Blader JC; Schooler NR; Jensen PS; Pliszka SR; Kafantaris V
    Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Disruptive Mood Dysregulation Disorder Symptoms (Irritable-Angry Mood and Temper Outbursts) Throughout Childhood and Adolescence in a General Population Sample.
    Mayes SD; Mathiowetz C; Kokotovich C; Waxmonsky J; Baweja R; Calhoun SL; Bixler EO
    J Abnorm Child Psychol; 2015 Nov; 43(8):1543-1549. PubMed ID: 26004122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.
    Farmer CA; Brown NV; Gadow KD; Arnold LE; Kolko DG; Findling RL; Molina BS; Buchan-Page KA; Rice RR; Bangalore SS; Bukstein O; Rundberg-Rivera EV; McNamara N; Aman MG
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):213-24. PubMed ID: 25885011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins?
    Fristad MA; Wolfson H; Algorta GP; Youngstrom EA; Arnold LE; Birmaher B; Horwitz S; Axelson D; Kowatch RA; Findling RL;
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):138-46. PubMed ID: 26859630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of disruptive mood dysregulation disorder in children with attention-deficit/hyperactivity disorder.
    Mulraney M; Silk TJ; Gulenc A; Efron D; Hazell P; Sciberras E
    J Affect Disord; 2021 Jan; 278():502-505. PubMed ID: 33017677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic Differences in Disruptive Mood Dysregulation Disorder Symptoms in ADHD, Autism, and General Population Samples.
    Mayes SD; Calhoun SL; Waxmonsky JG; Kokotovich C; Baweja R; Lockridge R; Bixler EO
    J Atten Disord; 2019 Jun; 23(8):849-858. PubMed ID: 27549781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between Disruptive Mood Dysregulation Disorder symptoms and sleep problems in children with and without ADHD.
    Waxmonsky JG; Mayes SD; Calhoun SL; Fernandez-Mendoza J; Waschbusch DA; Bendixsen BH; Bixler EO
    Sleep Med; 2017 Sep; 37():180-186. PubMed ID: 28899532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD.
    Blader JC; Pliszka SR; Jensen PS; Schooler NR; Kafantaris V
    Pediatrics; 2010 Oct; 126(4):e796-806. PubMed ID: 20837589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.